Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
University of Minnesota · McGill University Health Centre · +4 more institutions
Indexed incrossrefpubmed
Abstract
Background
No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective
To investigate whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients.
Citation impact
548
total citations
- FWCI
- 13.05
- Percentile
- 100%
- References
- 22
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Hydroxychloroquine
- Medicine
- Placebo
- Clinical endpoint
- Internal medicine
- Adverse effect
- Severity of illness
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.